← Leaderboards
Francois J Villinger
Emory University
$61,853,654
Attributed
$79,534,782
Total exposure
65
Grants
50
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$81,164,597 · 66
By mechanism
R01$38,303,300 · 12
U19$13,195,753 · 6
C06$9,505,599 · 3
R24$8,488,123 · 2
P01$6,058,714 · 4
P51$3,571,020 · 35
Top collaborators
- Philip J Santangelo23 shared
- Marie-Claire Elisabeth Gauduin7 shared
- Theresa L Chang5 shared
- Savita Pahwa5 shared
- Anthony T Podany2 shared
- Vijayakumar Velu2 shared
- Sylvain Fleury1 shared
- Elena Martinelli1 shared
Most similar at Emory University
Same institution · by research overlap
- Rafi Ahmed$104,632,759
- Carlos Del Rio$49,445,541
- Harriet L Robinson$13,479,393
- Francis J Novembre$5,562,216
- Jeffrey Lennox$30,661,826
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsInfectionMacaca MulattaMacacaIn VivoViralNonhuman PrimateMonkeysImmune ResponseHiv InfectionsVirusImmunePrimatesResponseSourceResourcesTissuesBaseBloodDoseVaccinesFundingIn VitroUnited States National Institutes Of Health
Grant awards (145)
Reversing effector-to-memory transition at ARTi to impact the HIV reservoir towards ART-free control$1,016,951
R01 · FY2025 · AI · contact PI
Durable HIV Vaccine Targeting Mucosal Epithelium$963,873
R01 · FY2025 · AI
Intrarectal Immunization for a Barrier to Mucosal HIV Infection$903,547
R01 · FY2025 · AI
IL-15 Therapy Combined with TGF-Beta Blockade for Sustained HIV Remission$800,389
R01 · FY2025 · AI
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir$766,944
R01 · FY2025 · DK
Durable Vaginal Protection from HIV via mRNA expression of BNABS$689,836
R01 · FY2025 · AI
Resource for Nonhuman Primate Immune Reagents$434,234
R24 · FY2025 · OD · contact PI
Intrarectal Immunization for a Barrier to Mucosal HIV Infection$984,626
R01 · FY2024 · AI
Durable HIV Vaccine Targeting Mucosal Epithelium$970,600
R01 · FY2024 · AI
IL-15 Therapy Combined with TGF-Beta Blockade for Sustained HIV Remission$927,200
R56 · FY2024 · AI
Durable HIV Vaccine Targeting Mucosal Epithelium$887,962
R01 · FY2024 · AI
Identification of SIV replication and reservoirs in the CNS$784,326
R01 · FY2024 · MH · contact PI
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir$732,404
R01 · FY2024 · DK
Durable Vaginal Protection from HIV via mRNA expression of BNABS$697,003
R01 · FY2024 · AI
Nonhuman Primate Core$517,623
P01 · FY2024 · AI · contact PI
Resource for Nonhuman Primate Immune Reagents$432,561
R24 · FY2024 · OD · contact PI
Vaccine against HCV in nonhuman primates$334,866
U19 · FY2024 · AI · contact PI
Expansion of Macaque Breeding runs at the New Iberia Research Center$3,999,070
C06 · FY2023 · OD · contact PI
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels$1,629,815
U19 · FY2023 · AI · contact PI
Durable HIV Vaccine Targeting Mucosal Epithelium$939,000
R01 · FY2023 · AI
Identification of SIV replication and reservoirs in the CNS$785,354
R01 · FY2023 · MH · contact PI
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir$762,285
R01 · FY2023 · DK
Nonhuman Primate Core$517,997
P01 · FY2023 · AI · contact PI
Resource for Nonhuman Primate Immune Reagents$431,279
R24 · FY2023 · OD · contact PI
Vaccine against HCV in nonhuman primates$122,522
U19 · FY2023 · AI · contact PI
âRenovation of Building 29 laboratories at the New Iberia Research Center"$2,000,000
C06 · FY2022 · OD · contact PI
Core D: Nonhuman Primates$1,527,673
P01 · FY2022 · AI · contact PI
Durable HIV Vaccine Targeting Mucosal Epithelium$989,873
R01 · FY2022 · AI
Identification of SIV replication and reservoirs in the CNS$838,128
R01 · FY2022 · MH · contact PI
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir$761,967
R01 · FY2022 · DK
Whole body to single cell analysis of the HIV reservoir$708,265
R01 · FY2022 · AI · contact PI
Durable Vaginal Protection from HIV via mRNA expression of BNABS$701,552
R01 · FY2022 · AI
Nonhuman Primate Core$532,414
P01 · FY2022 · AI · contact PI
Vaccine against HCV in nonhuman primates$439,478
U19 · FY2022 · AI · contact PI
Resource for Nonhuman Primate Immune Reagents$437,988
R24 · FY2022 · OD · contact PI
Novel Macaque Breeding Runs at the New Iberia Research Center$3,506,529
C06 · FY2021 · OD · contact PI
Identification of SIV replication and reservoirs in the CNS$838,128
R01 · FY2021 · MH · contact PI
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir$777,641
R01 · FY2021 · DK
Whole body to single cell analysis of the HIV reservoir$718,955
R01 · FY2021 · AI · contact PI
Durable Vaginal Protection from HIV via mRNA expression of BNABS$718,310
R01 · FY2021 · AI
Non-Human Primate and Imaging Core$461,371
P01 · FY2021 · AI · contact PI
Vaccine against HCV in nonhuman primates$288,771
U19 · FY2021 · AI · contact PI
Identification of SIV replication and reservoirs in the CNS$875,438
R01 · FY2020 · MH · contact PI
Durable vaginal protection from HIV via mRNA expression of bnAbs$729,421
R01 · FY2020 · AI
Whole body to single cell analysis of the HIV reservoir$729,273
R01 · FY2020 · AI · contact PI
Non-Human Primate and Imaging Core$484,787
P01 · FY2020 · AI · contact PI
Whole body to single cell analysis of the HIV reservoir$739,281
R01 · FY2019 · AI · contact PI
Antibody Responses in Aging SIV Infected Monkeys$733,027
R01 · FY2019 · AI
Non-Human Primate and Imaging Core$468,855
P01 · FY2019 · AI · contact PI
Monitoring SIV Reservoirs with Whole Body immunoPET$1,056,530
R01 · FY2018 · AI · contact PI
Antibody Responses in Aging SIV Infected Monkeys$815,288
R01 · FY2018 · AI
Whole body to single cell analysis of the HIV reservoir$758,619
R01 · FY2018 · AI · contact PI
Non-Human Primate and Imaging Core$471,691
P01 · FY2018 · AI · contact PI
Resource for Nonhuman Primate Immune Reagents$400,383
R24 · FY2018 · OD · contact PI
Monitoring SIV Reservoirs with Whole Body immunoPET$1,590,807
R01 · FY2017 · AI · contact PI
Antibody Responses in Aging SIV Infected Monkeys$817,006
R01 · FY2017 · AI
Non-Human Primate and Imaging Core$501,935
P01 · FY2017 · AI · contact PI
Resource for Nonhuman Primate Immune Reagents$378,290
R24 · FY2017 · OD · contact PI
Monitoring SIV Reservoirs with Whole Body immunoPET$1,043,190
R01 · FY2016 · AI · contact PI
Antibody Responses in Aging SIV Infected Monkeys$814,638
R01 · FY2016 · AI
Resource for Nonhuman Primate Immune Reagents$397,868
R24 · FY2016 · OD · contact PI
Antibody Responses in Aging SIV Infected Monkeys$827,888
R01 · FY2015 · AI
Macque$731,555
U19 · FY2015 · AI · contact PI
Monitoring SIV Reservoirs with Whole Body immunoPET$730,909
R01 · FY2015 · AI · contact PI
Macaque T cell signatures of Mtb control$646,350
U19 · FY2015 · AI · contact PI
Pre-Clinical Evaluation of mAb Microbicide Products in Nonhuman Primates$518,321
U19 · FY2015 · AI · contact PI
Resource for Nonhuman Primate Immune Reagents$504,257
R24 · FY2015 · OD · contact PI
Monitoring SIV reservoirs with whole body immunoPET$366,772
R01 · FY2015 · AI · contact PI
Macque$1,374,835
U19 · FY2014 · AI · contact PI
Monitoring SIV reservoirs with whole body immunoPET$1,031,739
R01 · FY2014 · AI · contact PI
Macaque T cell signatures of Mtb control$766,302
U19 · FY2014 · AI · contact PI
Pre-Clinical Evaluation of mAb Microbicide Products in Nonhuman Primates$669,102
U19 · FY2014 · AI · contact PI
Resource for Nonhuman Primate Immune Reagents$494,370
R24 · FY2014 · OD · contact PI
Macque$1,356,231
U19 · FY2013 · AI · contact PI
Pre-Clinical Evaluation of mAb Microbicide Products in Nonhuman Primates$583,157
U19 · FY2013 · AI · contact PI
Resource for Nonhuman Primate Immune Reagents$474,190
R24 · FY2013 · OD · contact PI
Macque$1,535,538
U19 · FY2012 · AI · contact PI
Pre-Clinical Evaluation of mAb Microbicide Products in Nonhuman Primates$515,328
U19 · FY2012 · AI · contact PI
Resource for Nonhuman Primate Immune Reagents$497,967
R24 · FY2012 · OD · contact PI
PD-1 modulation of SIV specific CD4 and CD8 T cell responses$465,133
R01 · FY2012 · AI · contact PI
Development of a non-invasive whole body contrast agent for virus detection$204,880
R21 · FY2012 · AI
Macque$1,194,109
U19 · FY2011 · AI · contact PI
PD-1 modulation of SIV specific CD4 and CD8 T cell responses$594,813
R01 · FY2011 · AI · contact PI
BIOLOGICAL MATERIAL PROCUREMENT PROGRAM$520,382
P51 · FY2011 · RR · contact PI
Resource for Nonhuman Primate Immune Reagents$510,411
R24 · FY2011 · RR · contact PI
Pre-Clinical Evaluation of mAb Microbicide Products in Nonhuman Primates$489,473
U19 · FY2011 · AI · contact PI
Development of a non-invasive whole body contrast agent for virus detection$256,568
R21 · FY2011 · AI
CD4 MEDIATED IMMUNE RECONSTITUTION IN SIV INFECTION$89,196
P51 · FY2011 · RR · contact PI
RESOURCE FOR NONHUMAN PRIMATE IMMUNE REAGENTS$74,294
P51 · FY2011 · RR · contact PI
A THERAPEUTIC VACCINE FOR EBV-ASSOCIATED MALIGNANCIES$74,294
P51 · FY2011 · RR · contact PI
PD-1 MODULATION OF SIV SPECIFIC CD4 AND CD8 T CELL RESPONSES$74,294
P51 · FY2011 · RR · contact PI
SIV INFECTION MODEL OF HIV INFECTION/DISEASE HIV ENTEROPATHY, GALT RESTORATION$74,294
P51 · FY2011 · RR · contact PI
TH17 CELLS IN AIDS PATHOGENESIS AND HIV VACCINES$74,294
P51 · FY2011 · RR · contact PI
INFECTION & IMMUNE RESPONSES TO A? HUMAN RETROVIRUS XMRV IN MACAQUES$49,412
P51 · FY2011 · RR · contact PI
BIOMARKERS ANALYSIS OF PREGNANT RHESUS MONKEYS$41,159
P51 · FY2011 · RR · contact PI
PD-1 modulation of SIV specific CD4 and CD8 T cell responses$673,668
R01 · FY2010 · AI · contact PI
Resource for Nonhuman Primate Immune Reagents$519,644
R24 · FY2010 · RR · contact PI
SPECIMEN COLLECTION AND DISTRIBUTION PROGRAM$383,791
P51 · FY2010 · RR · contact PI
INFECTION & IMMUNE RESPONSES TO A? HUMAN RETROVIRUS XMRV IN MACAQUES$65,793
P51 · FY2010 · RR · contact PI
CD4 MEDIATED IMMUNE RECONSTITUTION IN SIV INFECTION$65,793
P51 · FY2010 · RR · contact PI
PD-1 MODULATION OF SIV SPECIFIC CD4 AND CD8 T CELL RESPONSES$54,827
P51 · FY2010 · RR · contact PI
A THERAPEUTIC VACCINE FOR EBV-ASSOCIATED MALIGNANCIES$54,827
P51 · FY2010 · RR · contact PI
BIOMARKERS ANALYSIS OF PREGNANT RHESUS MONKEYS$54,827
P51 · FY2010 · RR · contact PI
SIV INFECTION MODEL OF HIV INFECTION/DISEASE HIV ENTEROPATHY, GALT RESTORATION$54,827
P51 · FY2010 · RR · contact PI
RESOURCE FOR NONHUMAN PRIMATE IMMUNE REAGENTS$54,827
P51 · FY2010 · RR · contact PI
TH17 CELLS IN AIDS PATHOGENESIS AND HIV VACCINES$54,827
P51 · FY2010 · RR · contact PI
PD-1 modulation of SIV specific CD4 and CD8 T cell responses$582,964
R01 · FY2009 · AI · contact PI
Renovation of the Yerkes NPRC Pathology laboratories$500,000
G20 · FY2009 · RR · contact PI
SPECIMEN COLLECTION AND DISTRIBUTION PROGRAM$396,830
P51 · FY2009 · RR · contact PI
Resource for Nonhuman Primate Immune Reagents$327,582
R24 · FY2009 · RR · contact PI
CD4 MEDIATED IMMUNE RECONSTITUTION IN SIV INFECTION$68,028
P51 · FY2009 · RR · contact PI
INFECTION & IMMUNE RESPONSES TO A? HUMAN RETROVIRUS XMRV IN MACAQUES$65,805
P51 · FY2009 · RR · contact PI
RESOURCE FOR NONHUMAN PRIMATE IMMUNE REAGENTS$56,690
P51 · FY2009 · RR · contact PI
Resource for Nonhuman Primate Immune Reagents$327,582
R24 · FY2008 · RR · contact PI
SPECIMEN COLLECTION AND DISTRIBUTION PROGRAM$203,968
P51 · FY2008 · RR · contact PI
CD4 MEDIATED IMMUNE RECONSTITUTION IN SIV INFECTION$81,625
P51 · FY2008 · RR · contact PI
RESOURCE FOR NONHUMAN PRIMATE IMMUNE REAGENTS$67,964
P51 · FY2008 · RR · contact PI
INFECTION & IMMUNE RESPONSES TO A? HUMAN RETROVIRUS XMRV IN MACAQUES$42,758
P51 · FY2008 · RR · contact PI
CD4 Immune Reconstitution in SIV Infection$422,404
R01 · FY2007 · HL · contact PI
Resource for Nonhuman Primate Immune Reagents$334,267
R24 · FY2007 · RR · contact PI
CD4 MEDIATED IMMUNE RECONSTITUTION IN SIV INFECTION$104,727
P51 · FY2007 · RR · contact PI
RESOURCE FOR NONHUMAN PRIMATE IMMUNE REAGENTS$65,453
P51 · FY2007 · RR · contact PI
CD4 Immune Reconstitution in SIV Infection$473,432
R01 · FY2006 · HL · contact PI
Resource for Nonhuman Primate Immune Reagents$369,250
R24 · FY2006 · RR · contact PI
CD4 MEDIATED IMMUNE RECONSTITUTION IN SIV INFECTION$59,665
P51 · FY2006 · RR · contact PI
RESOURCE FOR NONHUMAN PRIMATE IMMUNE REAGENTS$40,116
P51 · FY2006 · RR · contact PI
CD4 Immune Reconstitution in SIV Infection$498,241
R01 · FY2005 · HL
RESOURCE FOR NONHUMAN PRIMATE IMMUNE REAGENTS$304,000
R24 · FY2005 · RR
CO-STIMULATION OF MACAQUE CD4+ T CELLS BY CD3/CD28 PATHWAYS$52,438
P51 · FY2005 · RR
RESOURCE FOR NONHUMAN PRIMATE IMMUNE REAGENTS$32,021
P51 · FY2005 · RR
CD4 Immune Reconstitution in SIV Infection$544,913
R01 · FY2004 · HL
RESOURCE FOR NONHUMAN PRIMATE IMMUNE REAGENTS$304,000
R24 · FY2004 · RR
CD4 IMMUNE RECONSTITUTION IN SIV INFECTION$51,707
P51 · FY2004 · RR
RESOURCE FOR NONHUMAN PRIMATE IMMUNE REAGENTS$35,765
P51 · FY2004 · RR
CD4 Immune Reconstitution in SIV Infection$649,987
R01 · FY2003 · HL
RESOURCE FOR NONHUMAN PRIMATE IMMUNE REAGENTS$304,000
R24 · FY2003 · RR
IL-16 MEDIATED IMMUNE RECONSTITUTION DURING SIV INFRECTION$87,166
P51 · FY2003 · RR
CROSS PROTECTIVE RESPONSES AFTER INFECTION WITH NON-PATHOGENIC SIVHU ISOLATE$87,166
P51 · FY2003 · RR
CLONING, ANALYSIS &EXPRESSION OF NONHUMAN PRIMATE CYTOKINES$55,170
P51 · FY2003 · RR
RESOURCE FOR NONHUMAN PRIMATE IMMUNE REAGENTS$304,000
R24 · FY2002 · RR
CELL MEDIATED IMMUNE RESPONSES$159,181
P01 · FY2002 · AI
CELL MEDIATED IMMUNE RESPONSES$159,181
P01 · FY2001 · AI
CORE--EXPERIMENTAL IMMUNOLOGY FACILITY$0
P30 · FY2001 · DA
CELL MEDIATED IMMUNE RESPONSES$256,006
P01 · FY2000 · AI
CORE--EXPERIMENTAL IMMUNOLOGY FACILITY$153,440
P30 · FY2000 · DA